Loading...
Header Logo
Keywords
Last Name
Institution

PREMA ROBINSON

TitleAssociate Professor
InstitutionMD Anderson
DepartmentInfectious Diseases, Infection Control, and Employee Health
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    R01NS042604     (ROBINSON, PREMA)Jun 1, 2003 - May 31, 2010
    NIH/NINDS
    Neuropeptides in the pathogenesis of neurocysticercosis
    Role: Principal Investigator

    R21AI054205     (ROBINSON, PREMA)Jun 5, 2003 - May 31, 2006
    NIH/NIAID
    Substance P in pathogenesis of cryptosporidiosis in AIDS
    Role: Principal Investigator

    R03AI099405     (ROBINSON, PREMA)Aug 6, 2013 - Jul 31, 2015
    NIH/NIAID
    Role of STAT3 in the pathogenesis of Inflammatory Bowel Disease
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kasembeli MM, Bharadwaj U, Robinson P, Tweardy DJ. Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment. Int J Mol Sci. 2018 Aug 05; 19(8). PMID: 30081609.
      View in: PubMed
    2. Robinson P, Kasembeli M, Bharadwaj U, Engineer N, Eckols KT, Tweardy DJ. Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance. Biomed Res Int. 2016; 2016:1959270. PMID: 26981525.
      View in: PubMed
    3. Khumbatta M, Firozgary B, Tweardy DJ, Weinstock J, Firozgary G, Bhatena Z, Bulsara T, Siller R, Robinson P. Corrigendum to "Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis". Biomed Res Int. 2015; 2015:869648. PMID: 26078968.
      View in: PubMed
    4. Robinson P, Taffet GE, Engineer N, Khumbatta M, Firozgary B, Reynolds C, Pham T, Bulsara T, Firozgary G. Substance P receptor antagonism: a potential novel treatment option for viral-myocarditis. Biomed Res Int. 2015; 2015:645153. PMID: 25821814.
      View in: PubMed
    5. Khumbatta M, Firozgary B, Tweardy DJ, Weinstock J, Firozgary G, Bhatena Z, Bulsara T, Siller R, Robinson P. Somatostatin negatively regulates parasite burden and granulomatous responses in cysticercosis. Biomed Res Int. 2014; 2014:247182. PMID: 25530957.
      View in: PubMed
    6. Thacker SA, Robinson P, Abel A, Tweardy DJ. Modulation of the unfolded protein response during hepatocyte and cardiomyocyte apoptosis in trauma/hemorrhagic shock. Sci Rep. 2013; 3:1187. PMID: 23378918.
      View in: PubMed
    7. Robinson P, Garza A, Weinstock J, Serpa JA, Goodman JC, Eckols KT, Firozgary B, Tweardy DJ. Substance P causes seizures in neurocysticercosis. PLoS Pathog. 2012 Feb; 8(2):e1002489. PMID: 22346746.
      View in: PubMed
    8. Garza A, Tweardy DJ, Weinstock J, Viswanathan B, Robinson P. Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis. J Biomed Biotechnol. 2010; 2010:597086. PMID: 20150970.
      View in: PubMed
    9. Robinson P, Garza A, Moore J, Eckols TK, Parti S, Balaji V, Vallejo J, Tweardy DJ. Substance P is required for the pathogenesis of EMCV infection in mice. Int J Clin Exp Med. 2009; 2(1):76-86. PMID: 19436834.
      View in: PubMed
    10. Garza A, Weinstock J, Robinson P. Absence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection. J Parasitol. 2008 Dec; 94(6):1253-8. PMID: 18576810.
      View in: PubMed
    11. Robinson P, Martin P, Garza A, D'Souza M, Mastrangelo MA, Tweardy D. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice. J Parasitol. 2008 Oct; 94(5):1150-4. PMID: 18576802.
      View in: PubMed
    12. Garza A, Lackner A, Aye P, D'Souza M, Martin P, Borda J, Tweardy DJ, Weinstock J, Griffiths J, Robinson P. Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques. J Med Primatol. 2008 Jun; 37(3):109-15. PMID: 18547256.
      View in: PubMed
    13. Garza A, Castellanos-Gonzalez A, Castenallos-Gonzalez A, Griffiths J, Robinson P. Infection of immunocompetent mice with acid-water-pretreated Cryptosporidium parvum results in weight loss, and intestinal (structural and physiological) alterations. Parasitol Res. 2008 Feb; 102(3):457-63. PMID: 18040720.
      View in: PubMed
    14. Pantenburg B, Dann SM, Wang HC, Robinson P, Castellanos-Gonzalez A, Lewis DE, White AC. Intestinal immune response to human Cryptosporidium sp. infection. Infect Immun. 2008 Jan; 76(1):23-9. PMID: 17967863.
      View in: PubMed
    15. D'Souza M, Garza MA, Xie M, Weinstock J, Xiang Q, Robinson P. Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection. J Parasitol. 2007 Oct; 93(5):1121-7. PMID: 18163347.
      View in: PubMed
    16. Hernandez J, Lackner A, Aye P, Mukherjee K, Tweardy DJ, Mastrangelo MA, Weinstock J, Griffiths J, D'Souza M, Dixit S, Robinson P. Substance P is responsible for physiological alterations such as increased chloride ion secretion and glucose malabsorption in cryptosporidiosis. Infect Immun. 2007 Mar; 75(3):1137-43. PMID: 17158891.
      View in: PubMed
    17. Patil S, Robinson P, Actor JK, Baig S, White AC. Proinflammatory cytokines in granulomas associated with murine cysticercosis are not the cause of seizures. J Parasitol. 2006 Aug; 92(4):738-41. PMID: 16995390.
      View in: PubMed
    18. Dann SM, Wang HC, Gambarin KJ, Actor JK, Robinson P, Lewis DE, Caillat-Zucman S, White AC. Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium. J Infect Dis. 2005 Oct 01; 192(7):1294-302. PMID: 16136475.
      View in: PubMed
    19. Okhuysen PC, Chappell CL, Lewis DE, Robinson P, White AC. Treatment of chronic cryptosporidiosis in AIDS with rIL-12 induces an immune response associated with improvement but severe side-effects. AIDS. 2005 Aug 12; 19(12):1333-4. PMID: 16052094.
      View in: PubMed
    20. Kumar A, Murphy R, Robinson P, Wei L, Boriek AM. Cyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NF-kappaB transcription factor. FASEB J. 2004 Oct; 18(13):1524-35. PMID: 15466361.
      View in: PubMed
    21. Stringer JL, Marks LM, White AC, Robinson P. Epileptogenic activity of granulomas associated with murine cysticercosis. Exp Neurol. 2003 Oct; 183(2):532-6. PMID: 14552894.
      View in: PubMed
    22. White AC, Robinson P, Okhuysen PC. Human studies provide insight into the pathogenesis, immunology, and treatment of cryptosporidiosis. Clin Infect Dis. 2003 Oct 01; 37(7):989; author reply 989-90. PMID: 13130414.
      View in: PubMed
    23. Robinson P, Okhuysen PC, Chappell CL, Weinstock JV, Lewis DE, Actor JK, White AC. Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis. 2003 Jul 15; 188(2):290-6. PMID: 12854086.
      View in: PubMed
    24. Robinson P, White AC, Lewis DE, Thornby J, David E, Weinstock J. Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis. Infect Immun. 2002 Aug; 70(8):4534-8. PMID: 12117965.
      View in: PubMed
    25. Robinson P, Okhuysen PC, Chappell CL, Lewis DE, Shahab I, Lahoti S, White AC. Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection. Cytokine. 2001 Jul 07; 15(1):39-46. PMID: 11509007.
      View in: PubMed
    26. Okhuysen PC, Robinson P, Nguyen MT, Nannini EC, Lewis DE, Janecki A, Chappell CL, White AC. Jejunal cytokine response in AIDS patients with chronic cryptosporidiosis and during immune reconstitution. AIDS. 2001 Apr 13; 15(6):802-4. PMID: 11371698.
      View in: PubMed
    27. Robinson P, Okhuysen PC, Chappell CL, Lewis DE, Shahab I, Janecki A, White AC. Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms. Infect Immun. 2001 Feb; 69(2):1172-4. PMID: 11160015.
      View in: PubMed
    28. Robinson P, Okhuysen PC, Chappell CL, Lewis DE, Shahab I, Lahoti S, White AC. Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans. Infect Immun. 2000 Sep; 68(9):5405-7. PMID: 10948171.
      View in: PubMed
    29. White AC, Robinson P, Okhuysen PC, Lewis DE, Shahab I, Lahoti S, DuPont HL, Chappell CL. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J Infect Dis. 2000 Feb; 181(2):701-9. PMID: 10669358.
      View in: PubMed
    30. Robinson P, Atmar RL, Lewis DE, White AC. Granuloma cytokines in murine cysticercosis. Infect Immun. 1997 Jul; 65(7):2925-31. PMID: 9199468.
      View in: PubMed
    31. White AC, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol. 1997; 66:209-30. PMID: 9103671.
      View in: PubMed
    32. White AC, Baig S, Robinson P. Taenia saginata oncosphere excretory/secretory peptidases. J Parasitol. 1996 Feb; 82(1):7-10. PMID: 8627504.
      View in: PubMed
    33. Infection of immunocompetent mice with acid-water-pretreated Cryptosporidium parvum results in weight loss, and intestinal (structural and physiological) alterations (Parasitology Research DOI 10.1007/s00436-007-0785-3). Parasitology Research. 102:567.
    34. Erratum. BioMed Research International. 2015.
    35. Intestinal tnfa in cryptosporidiosis. Journal of Investigative Medicine. 44.
    36. Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance. BioMed Research International. 2016.
    ROBINSON's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description